Sugi Predict

Sugi Predict / Compounds / SCHEMBL1123331

SCHEMBL1123331

SCHEMBL1123331

Oc1ccccc1Oc1cc(Cl)c(Cl)cc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TTR P02766 5/20 0.48
▸ LMNA P02545 2/20 0.48
▸ MAPT P10636 2/20 0.48
▸ HPGD P15428 2/20 0.48
▸ NR1I2 O75469 1/20 0.48
▸ PGR P06401 1/20 0.48
▸ HSP90AA1 P07900 1/20 0.48
▸ ADORA3 P0DMS8 1/20 0.48
▸ HSPA5 P11021 1/20 0.48
▸ CBR1 P16152 1/20 0.48
▸ TBXA2R P21731 1/20 0.48
▸ SLC6A2 P23975 1/20 0.48
▸ AGTR1 P30556 1/20 0.48
▸ SLC6A3 Q01959 1/20 0.48
▸ STK39 Q9UEW8 1/20 0.45
▸ TSHR P16473 2/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1532088 0.81 ALDH1A1 (0.54) TTRLMNAMAPTHPGDNR1I2
SCHEMBL240470 0.81 TTR (0.76) TTRLMNAMAPTHPGDNR1I2
SCHEMBL29446988 0.80 CA2 (0.62) LMNAMAPTHPGDTSHRCA1
SCHEMBL18197 0.80 CA2 (0.62) LMNAMAPTHPGDTSHRCA1
SCHEMBL27429370 0.79 ALDH1A1 (0.52) TTRLMNAMAPTHPGDNR1I2
SCHEMBL11577191 0.78 TTR (0.79) TTRLMNAMAPTHPGDNR1I2
SCHEMBL6246195 0.78 SLC6A2 (0.40) TTRLMNAMAPTHPGDNR1I2
SCHEMBL7806601 0.78 CA2 (0.59) LMNAMAPTHPGDTSHRCA1
Phosphine SCHEMBL28067413 0.78 CA2 (0.59) LMNAMAPTHPGDTSHRCA1
Ammonia Solution, Strong SCHEMBL28322857 0.78 CA2 (0.59) LMNAMAPTHPGDTSHRCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2207416-B1 ENHANCED RETENTION CAPABILITIES THROUGH METHODS COMPRISING SURFACE TREATMENT OF FUNCTIONAL PARTICULATE CARRIER MATERIALS, AND FUNCTIONAL PARTICULATE CARRIER MATERIALS MADE THEREFROM IMERYS FILTRATION MINERALS INC (US) 2018-11-07 — — EP disclosed
US-20180296459-A1 COMPOSITIONS CONTAINING POLYMERIC, IONIC COMPOUNDS COMPRISING IMIDAZOLIUM GROUPS BASF SE (DE) 2018-10-18 — — US disclosed
EP-3378313-A1 COMPOSITIONS CONTAINING POLYMERIC, IONIC COMPOUNDS COMPRISING IMIDAZOLIUM GROUPS BASF SE (DE) 2018-09-26 — — EP disclosed
US-10016354-B2 Compositions containing polymeric, ionic compounds comprising imidazolium groups BASF SE (DE) 2018-07-10 — — US disclosed
EP-2688405-B1 COMPOSITIONS CONTAINING POLYMERIC, IONIC COMPOUNDS COMPRISING IMIDAZOLIUM GROUPS BASF SE (DE) 2017-11-22 — — EP disclosed
CN-103442567-B Containing the composition of polymerization plasma type compound comprising imidazole group BASF SE (DE) 2016-02-10 — — CN disclosed
CN-105165823-A Enhanced Retention Capabilities Through Methods Comprising Surface Treatment Of Functional Particulate Carrier Materials, And Functional Particulate Carrier Materials Made Therefrom WORLD MINERALS INC 2015-12-23 — — CN disclosed
EP-2899213-A1 Modified polysaccharides, method for their production and their use BASF SE (DE) 2015-07-29 — — EP disclosed
EP-2899214-A1 Ethylenically unsaturated polysaccharides, method for their production and their use BASF SE (DE) 2015-07-29 — — EP disclosed
US-20140148553-A1 REDUCED ALLERGENICITY OF NATURAL LATEX PRODUCT IMERYS FILTRATION MINERALS, INC. (US) 2014-05-29 — — US disclosed
US-20050009971-A1 Composition and use ARCH UK BIOCIDES 2005-01-13 — — US disclosed
US-20050008534-A1 Composition and use ARCH UK BIOCIDES 2005-01-13 — — US disclosed
WO-2004100666-A1 ANTIMICROBIAL COMPOSITION CONTAINING A POLYMERIC BIGUADINE AND A COPOLYMER AND USE THEREOF ARCH UK BIOCIDES LIMITED (GB) 2004-11-25 — — WO disclosed
WO-2004100663-A1 ANTIMICROBIAL COMPOPSITION COMPRISING A POLYMERIC BIGUANIDE AND A COPOLYMER AND THEIR USE THEREOF ARCH UK BIOCIDES LIMITED (GB) 2004-11-25 — — WO disclosed
WO-2004100664-A1 COMPOSITION COMPRISING AN ACIDIC COPOLYMER AND AN ANTIMICROBIAL AGENT AND USE THEREOF ARCH UK BIOCIDES LIMITED (GB) 2004-11-25 — — WO disclosed
WO-2004100665-A1 ANTIMICROBIAL COMPOSITION COMPRISING A POLYMERIC BIGUANIDE AND A COPOLYMER AND USE THEREOF ARCH UK BIOCIDES LIMITED (GB) 2004-11-25 — — WO disclosed
US-20040137202-A1 Multifunctional adhesive food wraps THE PROCTER & GAMBLE COMPANY 2004-07-15 — — US disclosed
WO-2004039683-A1 MULTIFUNCTIONAL ADHESIVE FOOD WRAPS THE PROCTER & GAMBLE COMPANY (US) 2004-05-13 — — WO disclosed
WO-2004030458-A1 MICROBICIDAL COMPOSITIONS AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 2004-04-15 — — WO disclosed
WO-1997045066-A1 URINARY MEDICAL DEVICES UROMED CORPORATION (US) 1997-12-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050008534-A1 Composition and use TST, TH, ARG1 TTR 3014/4885LMNA 4454/4885MAPT 4100/4885
US-20180296459-A1 COMPOSITIONS CONTAINING POLYMERIC, IONIC COMPOUNDS COMPRISING IMIDAZOLIUM GROUPS PUF60, POLR1C, PICALM TTR 830/4885LMNA 2122/4885MAPT 515/4885
US-10016354-B2 Compositions containing polymeric, ionic compounds comprising imidazolium groups PUF60, POLR1C, PICALM TTR 830/4885LMNA 2122/4885MAPT 515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.